Abstract
Amsterdam Law Forum (ALF) is the student-run 'International Law Journal' of VU University. Every year ALF publishes a winter, spring, and summer issue. The journal consists of three sections; scientific articles, opinion articles, and commentaries. As of this year, ALF also creates a section for inaugural speeches. In addition, ALF hosts a conference in spring with a relevant legal theme, where renowned speakers are invited to share their perspectives. Overall, ALF is a topical journal that provides a platform for established scholars and young academics to share knowledge, opinions and experiences and to make contributions to the international law discourse. Staff, PhD students and master students who have written a very good thesis are invited to submit an article to ALF. What is learned in the cradle is carried to the tomb: we are looking forward to sharing your articles on our website!
Highlights
A little over thirty years ago, bioethicists, lawmakers, and the public alike were engrossed by the birth of Louise Brown and the possibilities that assisted reproductive technology (ART) presented to us
Transplant medicine is regulated under the Human Tissue Act of 2004, while embryos and live gametes are regulated under the Human Fertilisation and Embryology Act (HFEA) of 1990.10 The HFEA, because it solely regulates ART and not transplant, does not deal with some of the potential issues raised in reproductive tissue transplant, like using deceased person‟s tissue, seeking consent from the deceased, allocating resources, and matching donors
Reproductive tissue transplant is an exciting development in the area of infertility treatments, but it poses new and challenging ethical and regulatory dilemmas
Summary
A little over thirty years ago, bioethicists, lawmakers, and the public alike were engrossed by the birth of Louise Brown and the possibilities that assisted reproductive technology (ART) presented to us. With the advent of ART came the development of whole markets around gestational surrogacy and egg/sperm donation These technologies transformed the way we think about reproduction, but they created countless regulatory and ethical challenges. Reproductive tissue transplants, involving the transplant of reproductive tissue like ovaries out of one body and back into that same body or a recipient, may hold the key to treating certain types of infertility, like congenital absence of reproductive organs or cancer-related infertility. Uterine transplants have shown some success in animal models, with human studies being planned.[6] Though the cases of ovarian and testicular transplant discussed above have involved tissue from living persons, deceased donor tissue has been conceived of as a potential resource as well, raising whole new issues around informed consent, as will be discussed later. With all the potential and power wielded by the prospect of reproductive tissue transplant, issues of appropriate regulatory and ethics governance are raised
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
